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Ensuring quality: a key consideration in scaling-up
HIV-related point-of-care testing programs
Peter N. Fonjungoa, Saladin Osmanova, Joel Kuritskyb,
Jean Bosco Ndihokubwayoc, Pam Bachanasa, Rosanna W. Peelingd,
Ralph Timperie, Glenn Finef, Wendy Stevensg, Vincent Habiyambereh
and John N. Nkengasonga
Objective: The objective of the WHO/US President’s Emergency Plan for AIDS Relief
consultation was to discuss innovative strategies, offer guidance, and develop a
comprehensive policy framework for implementing quality-assured HIV-related
point-of-care testing (POCT).
Methods: The consultation was attended by representatives from international
agencies (WHO, UNICEF, UNITAID, Clinton Health Access Initiative), United States
Agency for International Development, Centers for Disease Control and Prevention/
President’s Emergency Plan for AIDS Relief Cooperative Agreement Partners, and
experts from more than 25 countries, including policy makers, clinicians, laboratory
experts, and program implementers.
Main outcomes: There was strong consensus among all participants that ensuring
access to quality of POCT represents one of the key challenges for the success of HIV
prevention, treatment, and care programs. The following four strategies were recom-
mended: implement a newly proposed concept of a sustainable quality assurance cycle
that includes careful planning; definition of goals and targets; timely implementation;
continuous monitoring; improvements and adjustments, where necessary; and a
detailed evaluation; the importance of supporting a cadre of workers [e.g. volunteer
quality corps (Q-Corps)] with the role to ensure that the quality assurance cycle is
followed and sustained; implementation of the new strategy should be seen as a step-
wise process, supported by development of appropriate policies and tools; and joint
partnership under the leadership of the ministries of health to ensure sustainability of
implementing novel approaches.
Conclusion: The outcomes of this consultation have been well received by program
implementers in the field. The recommendations also laid the groundwork for devel-
oping key policy and quality documents for the implementation of HIV-related POCT.
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Introduction
There has been significant progress in expanding HIV
prevention, treatment, and care programs over the past
decade [1]. Despite these gains there are still challenges
across the continuum of treatment and care cascade
beginning with diagnosis, initiation of treatment, and
clinical monitoring. There is a significant proportion of
undiagnosed HIV cases, which prevents individuals from
having access to existing prevention and treatment
services. There are an estimated 35 million individuals
living with HIV worldwide; 54% (19 million) do not
know their HIV-positive status, and only 42% of children
born to HIV-positive mothers receive an HIV test within
the first 8 weeks of life in low and middle-income
countries [2]. The coverage of people on antiretroviral
therapy remains low; the percentage of people with HIV
not on antiretroviral therapy decreased by only 27% from
90% in 2006 to 63% in 2013, with only 28% of children
on antiretroviral therapy worldwide [2]. Furthermore,
with the new Joint United Nations Program on HIVand
AIDS (UNAIDS) treatment targets of ‘90 90 90 by
2020’, which is: 90% of all people living with HIV know
their status; 90% of all people diagnosed with HIVare on
sustained antiretroviral therapy, and 90% of all people
receiving antiretroviral therapy have viral suppression [3],
there are still significant gaps to be overcome to reach
each of the targets. The recently launched diagnostics
access initiative emphasizes that to achieve these targets
there will be a need to develop innovative strategies that
expand access to affordable diagnostic assays followed by
immediate access to effective prevention, treatment, and
care programs [4].
Point-of-care testing has the potential to increase access to
patient diagnosis and treatment if properly deployed.
There is a plethora of HIV-related point-of-care
diagnostics (HIV rapid diagnostic tests, CD4þ enumer-
ation, early infant diagnosis, viral load), syphilis, malaria,
cryptococcal infection, and tuberculosis [5,6]. Although
these technologies have been scaled-up rapidly world-
wide, corresponding quality assurance programs have not
kept pace. Unfortunately, these inadequacies may partly
be responsible for HIV misdiagnosis with significant
psychosocial and program consequences [7,8]. In HIV
programs in the Democratic Republic of Congo,
Burundi, and Ethiopia, 10.3, 2.6, and 4.7% false positive
HIV results, respectively, were given to participants with
devastating consequences of abandonment by partners
and inappropriate initiation on treatment [9]. Also, high
rates (10.5%) of false-positive were observed in large
voluntary counseling and testing program centers in
Democratic Republic of Congo using HIV rapid test
parallel testing [10]. HIV misdiagnosis and inappropriate
initiation of individuals on treatment led WHO to
reinforce its retesting strategy on newly diagnosed
individuals prior to initiation on antiretroviral therapy
[11,12].
Point-of-care testing (POCT) would be indispensable in
realizing the efforts of nations and partners to achieve an
AIDS-free generation through the implementation of
‘test and treat strategies’; identifying pregnant women for
option Bþ; and attaining the UNAIDS 90 90 90
goals percentage of people on treatment and virally
suppressed by 2020 [3,11]. For instance, HIV rapid
diagnostic tests are one of the most widely used POCT
for screening individuals. In 2012 WHO estimated HIV
testing and counseling of more than 118 million
individuals in low and middle-income countries [13].
The large number of POCT performed creates major
challenges for program managers and implementers, and
thus requires innovative quality assurance strategies to
ensure the accuracy and reliability of test results.
The paper reviews the objectives and outcomes of several
international consultations on quality of HIV-related
POCT following the initial consultation in Atlanta. The
objectives of the meeting were to discuss innovative
strategies for quality assurance, offer guidance, and
develop a comprehensive policy framework for imple-
menting quality-assured HIV-related POCT.
Consultation
Cognizant of the quality challenges associated with large-
scale use of POCT, WHO, CDC, and President’s
Emergency Plan for AIDSRelief (PEPFAR) coorganized
a stakeholder consultation on ‘Innovative Strategies to
Ensure the Quality of HIV-Related Point-of-Care
Testing (POCT).’ The meeting held on February
27–28, 2014, brought together representatives from
international agencies (WHO, UNICEF, UNITAID,
CHAI, USAID, CDC/PEPFAR Cooperative Agree-
ment Partners) and 126 experts from a wide-ranging
background, including those with extensive experience
in implementing programs, developing policies, and
diagnostic experts to discuss novel strategies to implement
effective and comprehensive quality assurance programs
for HIV-related POCT. The consultation format
included a series of technical sessions in which experts
provided presentations and experience in aspects of
ensuring the quality of HIV rapid and POCT programs.
After each session the participants worked in small
technical working groups (TWGs) to discuss and develop
key points to be considered by partners in the
development and implementation of this strategy, which
were discussed and adopted at the final closing session.
Main outcomes and recommendations
After two days of discussions, including presentations and
sharing of field experiences, participants reached con-
sensus on five points:
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(1) Endorse the concept of the quality assurance cycle (QAC)
which at a minimum includes proficiency testing
program, site support visits, collection and analysis of
data, and ensuring corrective actions are accomplished.
(2) Employ strategies that include the development of a new
cadre of workers (e.g. Q-Corps as community-based
champions) to promote the accomplishment of the
QAC.
(3) Adopt a step-wise process for continuous improvement
of HIV-related POCTwhich would lead to certification
of individuals and sites.
(4) Advocate for implementation of quality-assured
POCTand finalization of policy framework developed
at the African Society of Laboratory Medicine
(ASLM)/Joint United Nations Programme on HIV/
AIDS (UNAIDS)/WHO joint meeting in Tanzania,
June 2014.
(5) Support the Ministry of Health (MOH) Ministerial
Panel endorsement for accuracy of HIV-related POCT
diagnosis at ASLM 2014.
Promoting innovation to increase the
uptake, coverage, and impact of the
quality-assured HIV-related point-of-care
testing
With the large increase in the use of HIV-related POCT,
there is the need for new ways to monitor and strengthen
testing sites to ensure quality results. The discussions
focused on innovative strategies to ensure completion of
the QAC. The major conclusions are described here.
The quality assurance cycle
TheQACentails threemajor phases (Fig. 1) with specific
tasks. The emphasis on the QAC is to ensure the whole
cycle or activities of the various phases are completed.
The quest for completing the QAC cycle was partly
informed by field experiences, instances when quality
indicators (e.g. proficiency testing) were being imple-
mented but the data or results were not collected and/or
analyzed and used for corrective actions, as needed, for
program improvement. The inability to complete the
whole QAC and focusing only on increased coverage,
made this exercise more of a quantity-oriented rather
than its intended quality-oriented purpose. It is critical
that each quality indicator being implemented goes
through all the phases. For example, the dried tube
specimen (DTS) proficiency testing panel program
should be planned with baseline and target number of
sites established. Then implementation through training
and monitoring, including the use of MOH staff or local
partners and Q-Corps, followed by improvement
through site support visits with corrective actions.
Finally, the program should be evaluated for impact
by the MOH and/or through local implementing
partners or institutions. These sequential phases with
the use of innovative strategies will ensure that the
QAC is completed with impact on reducing the rate of
misdiagnoses.
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Plan
Define
Implement
Monitor
Improve
Evaluate
•    Engage leadership, partners and relevant
     stakeholders
•    Develop policies with QA in national plan
•    Develop implementation plan
•    Advocacy for QA of POCT
•    Develop standard training materials, SOPs,
     data collection, monitoring and evaluation
     tools for QA
•    Establish a functional QA coordination team
•    Adequate human and financial resources
•    Define expected quality of POCT
•    Define roles and responsibilities of partners and
     stakeholders
•    Define indicators for monitoring quality of POCT
•    Set targets, identify site and conduct situational
     analysi
•    Train and certify staff performing POCT
•    Assess and certify sites performing POCT
•    Implement QA activities (e.g. PT, logbook.)
•    Strengthen logistics & supply chain
•    Conduct site supportive supervision
•    Generate and document QA activities or
      report
•    Use of local partners, private public
      partnership, community champions
•    Analyze/review periodically POCT staff
     performance
•    Analyze/review periodically QA results
•    Review QA collection tools
•    Review periodically POCT inventory and
     logistic
•    Use of local partners, private public
     partnership, community champions
•    Evaluation of program to assess impact
•    Identify and encourage use of best practices
•    Disseminate findings
•    Provide and monitor corrective actions
•    Use of local partners, private public
     partnership, community champions
•    Strengthen country ownership
Quality assurance
cycle 
Phase I: planning
Phase II: implement
Phase III: sustainability
Fig. 1. The quality assurance cycle depicting the three main phases: plan (phase I), implement (phase II), and sustain (phase III),
with roles and activities (shown in boxes) for each phase for HIV-related point-of-care testing quality system. POCT, point-of-
care testing; PT, proficiency testing; QA, quality assurance.
Volunteer quality corps or community-based
champions
One of the main challenges experienced in the field with
completing the QAC has been the shortage of human
resources that are required to ensure completion of the
necessary tasks of the QAC. An approach of engaging a
new cadre of community-based champions, the Q-
Corps, was discussed and endorsed. The Q-Corps
concept is modeled on the US Peace Corps program
used to support and improve community projects in
various departments including health, agriculture, and
education. The Q-Corps would be mobilized from the
community through an advertisement, for example, in a
local newspaper, which would list the minimum standards
required for performing duties associated with QAC. The
Q-Corps could, for instance, be graduates from medical
laboratory training schools or universities, other health-
care professionals, preferably with a background in natural
sciences. One of their roles would be to work directly
with testing sites on various activities or tasks to improve
the quality of testing at the site.
Prior to commencement, the Q-Corps would undergo
standard training for two weeks on HIV testing
algorithm, QAC, practical hands-on experience and
interpretation of results, quality assurance, documen-
tation, safety, troubleshooting, and how to assess testing
sites using a standard checklist. Tasks the Q-Corps would
perform include:
(1) distribution of proficiency testing panels;
(2) collection of proficiency testing results from enrolled
labs and their analysis;
(3) training on correct utilization of standard HIV logbook
for data collection;
(4) entry and analysis of standard logbook data; and,
(5) relaying site challenges to appropriate MOH officials
or department.
Additionally, the Q-Corps would provide site supportive
supervision which would allow providing on-the-spot
corrective actions. It was emphasized that Q-Corps is not
a stand-alone program but is integrated within the MOH
system, is supervised by the MOH, and encourages
partnership with local implementing partners
for sustainability.
Creation of a network of testers within
communities
This approach includes establishing a database of certified
testers. This database would include those who have been
trained and certified competent to perform a POCT test.
For cascading of training, only certified testers would
provide further training. This would limit suboptimal
training that is often not standardized and does not
provide a practical hands-on component. The network of
testers could be structured along the tiered healthcare
delivery system (national, regional, district, and com-
munity level). Certification of testers should be for a
specified duration after which recertification should
be performed.
Stepwise process for continuous improvement of
HIV-related point-of-care testing
POCT is mostly used outside the traditional laboratory
settings, for instance, at voluntary counseling and testing
and antenatal care sites where they are used by lay
counsellors, nurses, and health extension workers. These
sites lack standard oversight to regularly monitor and
ensure quality of testing when compared with labora-
tories where the WHO/Stepwise Laboratory Quality
Improvement Process Towards Accreditation checklist is
available for use in monitoring laboratories. This has
fueled the perception of double standards that may
compromise quality of POCToutside laboratory settings.
The checklist would address this gap and enable a standard
approach to monitoring these testing sites.
Establishing and/or engaging new partnerships
No single group can deliver or ensure quality within the
health system. Over reliance on the MOHs to implement
these activities can be burdensome and ineffective. New
partnerships including using local implementing partners
or institutions and public private partnerships to increase
uptake, coverage, and quality of HIV-related POCT
should be established.
The innovative approaches would need to be coordinated
within the MOH structure. The MOH would need to
provide strong leadership and oversight in creating an
enabling environment and conditions for partnership
with the private sector and local partners to use novel
strategies, such as the Q-Corps, to support quality
assurance programs.
Postmeeting recommendation
implementation
Following the consultation, many of the meeting
recommendations have been pilot tested with successful
outcomes as indicated below. For instance, field
implementation of the Q-Corps with emphasis on the
QAC, stepwise process for improving the quality of HIV
rapid testing has been successfully implemented.
Cameroon experience with implementing the
quality assurance cycle and quality assurance
cycle; volunteer quality corps
With direct technical assistance from CDC/PEPFAR,
Cameroon successfully launched implementation of the
QAC using Q-Corps, the DTS proficiency testing
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program, and the standardized HIV logbook in May
2014. The MOH fully endorsed and embraced the QAC
and the Q-Corps initiative and provided strong leadership
for its launch. Through the leadership of the MOH and
PEPFAR teams in Cameroon, 31 Q-Corps staff were
recruited and trained on QAC, DTS, HIV logbook, data
management, biosafety, and troubleshooting approaches.
PEPFAR Cameroon and the MOH engaged a local
partner, Global Health System Solution, who recruited
the Q-Corps staff through a competitive process. The
local partner manages Q-Corps expenses on transpor-
tation, accommodations, reservations, and meals and
incidentals as they conduct regularly scheduled site visits.
The Q-Corps visited more than 75 sites by August 2014
implementing QAC using DTS proficiency testing and
standardized logbook. The Q-Corps also implemented
the stepwise process for improving the quality of HIV-
related POCT checklist. The Q-Corps appreciated the
opportunity to serve and improve the quality of testing in
their communities, with preliminary results that indicated
that with the Q-Corps turn-around time to receive
proficiency testing results from participating sites was
reduced from 30 days to 5 days. Additionally, the Q-
Corps provided on-the-spot corrective actions for sites
they distributed proficiency testing panels. Enrolled sites
have expressed satisfaction at the attention, supervision,
and timely necessary corrective actions.
African Society of Laboratory Medicine WHO
Tanzania meeting, June 23–25, 2014
Tanzania, ASLM, and WHO convened a meeting on
June 23–25, 2014 bringing together policy makers,
programmanagers, clinicians, scientists, local implement-
ing partners, and agencies to discuss the draft products of
the WHO/PEPFAR February 27–28, 2014 consultation
in Atlanta, namely: recommendations for innovative
strategies and guidance for implementing quality-assured
HIV-related POCT; and a consensus policy framework
document for implementing quality-assured HIV-related
POCT. The two documents were presented to the larger
forum at the meeting and there was broad consensus.
Countries endorsed the documents with each country
committed to developing an implementation plan with
targets and indicators to translate the document into
action (Table 1).
WHO/African Society of Laboratory Medicine
advocacy on innovative strategies
WHO and ASLM have taken a critical role in advocating
the uptake and implementation of meeting recommen-
dations. In addition to convening meetings to write up
the policy and quality assurance documents, they have
written to MOHs of African member states; for instance,
theMOHof Cameroon, to encourage implementation of
the QAC and innovative strategies to ensure the cycle
is completed.
Expanding the innovative strategy to other
President’s Emergency Plan for AIDS Relief -
supported regions
Copenhagen, Denmark June 19–21, 2014
The International Laboratory Branch of the Division of
Global HIV/AIDS at CDC and WHO Europe Office
held a three-day meeting from June 19–21, 2014 in
Copenhagen, Denmark to engage 10 PEPFAR-sup-
ported countries from Central Asia and Eastern Europe
on HIV rapid test quality improvement initiative
principles and efforts, and POCTas a whole. Participants
included senior program managers, laboratory experts,
and policy makers; the Ukrainian Vice Minister of Health
also attended the meeting. The initiative was welcomed
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Table 1. Summary consultations on increased access and quality assured point-of-care testing.
Consultation Date Main outcome
WHO/ASLM, Dar es Salaam, Tanzania meeting on
improving access and increasing quality of HIV rapid
testing in Africa
June 2014 Endorsement of the quality assurance cycle by ministries of health
Endorsement of two draft WHO documents: strategies and guidance
for implementing quality-assured HIV-related point-of-care
testing; and Consensus policy framework document for
implementing quality-assured HIV-related point-of-care testing
Commitment to implement innovative approaches to ensure closing
of the quality assurance cycle and to improve quality of HIV rapid
testing
CDC/PEPFAR/WHO Euro, Copenhagen, Denmark on
HIV rapid test quality improvement initiative in Central
Asia and Eastern Europe
June 2014 Endorsement of initiative to improve quality of HIV rapid testing
WHO/PAHO, UNAIDS, PEPFAR, Port of Spain, Trinidad,
and Tobago on access to quality HIV-related
diagnostics
October 2014 Access to quality HIV-related diagnostics as a human right
entitlement
Endorsement of the QAC and innovative approaches to improve
quality of HIV-related diagnostics
Call for creation of Caribbean technical working group to facilitate
implementation of access and quality of HIV-related point-of-
care testing diagnostics
ASLM, African Society for Laboratory Medicine; CDC, Centers for Diseases Control and Prevention; PAHO, Pan American Health Organization;
PEPFAR, President’s Emergency Plan for AIDS Relief; QAC, Quality Assurance Cycle; UNAID, Joint United Nations Programme on HIV; WHO,
World Health Organization.
in the region, and the Regional Director of WHO
Europe expressed strong support and recommended
that the planned activities be included in the WHO
Global and European Regional Action Plan 2015–2020
to ensure high-quality standards and proficiency in HIV
rapid testing and POCT (Table 1). For this purpose a
regional TWG has been established, represented by
experts from Eastern Europe and Central Asia, which
will provide advice and technical guidance for developing
and implementing priority activities in the area of
the diagnostics access initiative and in achieving the
90 90 90 targets.
Port of Spain, Trinidad, and Tobago, October 20–23,
2014
WHO/Pan American Health Organization, UNAIDS,
PEPFAR/CDC and partners convened fromOctober 20–
23, 2014 to review the quality of HIV-related POCTand
care and treatment targets. Recognizing the challenge of
quality HIV rapid testing and its devastating consequences
to individuals, families, and communities, the participants
resolved to create aCaribbeanTWGtoassistwith increased
access to quality HIV-related point-of-care diagnoses and
to allocate funding to improve the quality of HIV-related
POCT toward achieving the UNAIDS 90 90 90
targets. The meeting ended with a call to action and a
final declaration statement ‘access to quality assured
HIV-related diagnostics as a human rights entitlement
of residents of the Caribbean Region’ (Table 1).
In Conclusion
Accurate and reliable results using HIV-related POCT
remains a priority in healthcare programs. Consensus on
strategies to improve the quality of diagnosis, and increase
uptake and coverage has been well received by program
implementers.The recommendations also laid the ground-
work for developing key policy and quality documents for
the implementation of HIV-related POCT.
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